Device Trial Radar · NCT06973265
Effects of Transcutaneous Electrical Nerve Stimulation on Breast Surgery
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
53
Actual
Start
Jul 1, 2024
Primary completion
Jul 1, 2025
Study completion Jul 30, 2025
Sponsor
- Lead sponsor
- Seda AkutayAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Scientific and Technological Research Council of Turkey
- First posted
- May 15, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (care provider)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this randomized controlled trial was to evaluate the effects of transcutaneous electrical nerve stimulation (TENS) on postoperative pain, lymphedema development, shoulder range of motion, and quality of life in women undergoing breast cancer surgery after neoadjuvant chemotherapy. The main questions it aims to answer are: Does TENS reduce postoperative pain? Does TENS prevent postoperative lymphedema? Does TENS increase postoperative shoulder range of motion? Does TENS improve postoperative quality of life? The researchers will compare the effects of TENS after breast surgery with a control group. Participants will be assessed for pain, lymphedema development, and shoulder range of motion before surgery, on the first day after surgery, at the first month after surgery, and at the third month after surgery. Quality of life will be assessed before surgery, at the first month after surgery, and at the third month after surgery.
Conditions
- Breast Cancer Surgery
- Transcutaneous Electric Nerve Stimulation
Interventions
TENSDevice
After the surgery, 2 TENS electrodes will be placed on the inner part of the upper arm of the patient's arm on the side where surgery was performed, and the frequency will be 100 Hz, the pulse duration will be 100 µs and the amplitude will be adjusted so as not to cause muscle contraction, and a 20-minute TENS application will be performed.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain intensityTime frame: Until the end of 3 month
- Lymphedema severityTime frame: Until the end of 3 month
- Shoulder and arm mobilityTime frame: Until the end of 3 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Erciyes University
Kayseri, Kayseri, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.